SpheroidPicker for automated 3D cell culture manipulation using deep learning

Istvan Grexa1,2, Akos Diosdi1,3, Maria Harmati1

  • 1Synthetic and Systems Biology Unit, Biological Research Centre (BRC), Eötvös Loránd Research Network (ELKH), Temesvári körút 62, Szeged, 6726, Hungary.

Scientific Reports
|July 21, 2021
PubMed

Insights

A new AI-guided system automates 3D cell culture transfer for cancer research. This innovation standardizes sample preparation, crucial for developing effective anticancer therapies and advancing precision medicine.

Area of Science:

  • Oncology
  • Biotechnology
  • Medical Technology

Background:

  • Cancer affects millions in Europe, with high-throughput screening of cell cultures dominating anticancer therapy research.
  • Patient-derived ex vivo 3D cell cultures are increasingly vital for drug discovery and precision medicine.
  • Standardized sample preparation is a critical unmet need in 3D cell culture screening for drug development.

Purpose of the Study:

  • To introduce an artificial intelligence-guided, low-cost 3D cell culture delivery system.
  • To address the need for standardized and robust sample preparation in 3D cell culture screening.
  • To enhance experimental control and reduce sample variability in cancer research.

Main Methods:

  • Development of an AI-guided system integrating a light microscope, micromanipulator, syringe pump, and computer.
  • Implementation of morphology-based feature analysis for spheroid selection based on size and shape.
  • Automated transfer of spheroids from standard holders (Petri dishes, microwell plates) to various formats up to 384-well plates.

Main Results:

  • The system enables reliable semi- and fully automated spheroid transfer.
  • Morphology-based analysis allows for the selection of uniform spheroids.
  • The device facilitates controlled experimental conditions by minimizing sample variability.

Conclusions:

  • The AI-guided 3D cell culture delivery system offers a standardized approach to sample preparation.
  • This technology is poised to reduce non-trivial side effects from sample variability in drug discovery.
  • The system represents a significant step towards next-generation precision medicine in oncology.

Related Concept Videos